Trial intelligence / Profile preview

Albumin kinetics by 123I-HSA vs SERALB-125 in healthy volunteers

2012-002638-35Phase 4Active

Sponsor
Region Stockholm
Start
Jun 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of albumin (human), sponsored by Region Stockholm. Primary endpoint: Transcapillary escape rate for albumin. Started Jun 2012; status: active.

02

Drugs

albumin (human)

Beyond the preview

Go deeper on 2012-002638-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002638-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call